Quentin Florence,Nanda Menon,William Moffitt,Bill Lunsford, III
申请号：
US16250733
公开号：
US20190211086A1
申请日:
2019.01.17
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates, in part, to isolated antibodies that specifically interact with and show measurable binding affinity to an epitope of the tau protein. Such antibodies may be used for the modulation of tau activity and/or aggregation, to study the effects of the tau protein on cell function and, in certain embodiments, for the treatment and/or prevention of a disease or condition associated with neurodegenerative tauopathy.
